Andrew Joseph Muir, MD

Professor of Medicine
Chief, Division of Gastroenterology in the Department of Medicine
Member in the Duke Clinical Research Institute
Campus mail 03137B Hosp South, Durham, NC 27710
Phone (919) 684-2052
Email address andrew.muir@duke.edu
  • Hepatitis C 
  • Primary sclerosing cholangitis
  • Cirrhosis
  • Liver Transplantation
  • Clinical Trials
  • Healthcare disparities in liver disease 
  • Outcomes Research
In Their Words

Education and Training

  • Fellow in Gastroenterology, Medicine, Duke University, 1998 - 2000
  • Chief Medical Resident, Medicine, Duke University, 1997 - 1998
  • Fellow in Gastroenterology, Medicine, Duke University, 1996 - 1997
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.H.S., Duke University, 2001
  • M.D., Duke University, 1993

Publications

Jou, JH, and Muir, AJ. "Hepatocellular Carcinoma Surveillance." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 16, no. 1 (January 2018): 19-20.

PMID
28694129
Full Text

Henson, JB, Patel, YA, Wilder, JM, Zheng, J, Chow, S-C, King, LY, and Muir, AJ. "Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis." Digestive Diseases and Sciences 62, no. 11 (November 2017): 3200-3209.

PMID
28391417
Full Text

Muir, AJ, Taghipour, M, Hassanzadeh, E, Sahni, VA, Sainani, N, Shiffman, ML, Ding, D, Jia, C, McColgan, BJ, Myers, RP, Subramanian, M, McHutchison, JG, Goodman, ZD, Eksteen, B, Manns, MP, Levy, C, Bowlus, CL, Chapman, RW, and Tempany-Afdhal, C. "Radiologic progression in primary sclerosing cholangitis (PSC) by two-dimensional magnetic resonance cholangiopancreatography (MRCP): Prospective data from a randomized controlled trial." 68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting. Washington, DC. October 20, 2017 - October 24, 2017.: WILEY, October 1, 2017.

Scholars@Duke

Muir, AJ, Taghipour, M, Hassanzadeh, E, Sahni, VA, Sainani, N, Shiffman, ML, Ding, D, Jia, C, McColgan, BJ, Myers, RP, Subramanian, M, McHutchison, JG, Goodman, ZD, Eksteen, B, Manns, MP, Levy, C, Bowlus, CL, Chapman, RW, and Tempany-Afdhal, C. "Radiologic progression in primary sclerosing cholangitis (PSC) by two-dimensional magnetic resonance cholangiopancreatography (MRCP): Prospective data from a randomized controlled trial." 68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting. Washington, DC. October 20, 2017 - October 24, 2017.: WILEY, October 1, 2017.

Scholars@Duke

Muir, AJ, Taghipour, M, Hassanzadeh, E, Sahni, VA, Sainani, N, Ding, D, Jia, C, McColgan, BJ, Chung, C, Myers, RP, Subramanian, M, McHutchison, JG, Goodman, ZD, Eksteen, B, Manns, MP, Chapman, RW, Bowlus, CL, Levy, C, and Tempany-Afdhal, C. "A risk prediction score based on magnetic resonance cholangiopancreatography (MRCP) accurately predicts disease progression in patients with primary sclerosing cholangitis (PSC)." 68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting. Washington, DC. October 20, 2017 - October 24, 2017.: WILEY, October 1, 2017.

Scholars@Duke

Muir, AJ, Taghipour, M, Hassanzadeh, E, Sahni, VA, Sainani, N, Ding, D, Jia, C, McColgan, BJ, Chung, C, Myers, RP, Subramanian, M, McHutchison, JG, Goodman, ZD, Eksteen, B, Manns, MP, Chapman, RW, Bowlus, CL, Levy, C, and Tempany-Afdhal, C. "A risk prediction score based on magnetic resonance cholangiopancreatography (MRCP) accurately predicts disease progression in patients with primary sclerosing cholangitis (PSC)." 68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting. Washington, DC. October 20, 2017 - October 24, 2017.: WILEY, October 1, 2017.

Scholars@Duke

Tempany-Afdhal, C, Taghipour, M, Behringer, PA, Hassanzadeh, E, Sahni, VA, Sainani, N, Ding, D, Zhang, J, McColgan, BJ, Chung, C, Myers, RP, Subramanian, M, McHutchison, JG, Goodman, ZD, Eksteen, B, Manns, MP, Chapman, RW, Bowlus, CL, Levy, C, and Muir, AJ. "Quantification of biliary tree volume in patients with PSC using three dimensional (3D) reconstruction of magnetic resonance cholangiopancreatography (MRCP): Clinical associations and prognostic significance." 68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting. Washington, DC. October 20, 2017 - October 24, 2017.: WILEY, October 1, 2017.

Scholars@Duke

Tempany-Afdhal, C, Taghipour, M, Behringer, PA, Hassanzadeh, E, Sahni, VA, Sainani, N, Ding, D, Zhang, J, McColgan, BJ, Chung, C, Myers, RP, Subramanian, M, McHutchison, JG, Goodman, ZD, Eksteen, B, Manns, MP, Chapman, RW, Bowlus, CL, Levy, C, and Muir, AJ. "Quantification of biliary tree volume in patients with PSC using three dimensional (3D) reconstruction of magnetic resonance cholangiopancreatography (MRCP): Clinical associations and prognostic significance." 68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting. Washington, DC. October 20, 2017 - October 24, 2017.: WILEY, October 1, 2017.

Scholars@Duke

Harrison, SA, Abdelmalek, MF, Diehl, AM, Caldwell, S, Shiffman, ML, Ghalib, R, Lawitz, E, Rockey, DC, Schall, REA, Jia, C, McColgan, BJ, Myers, RP, Subramanian, M, McHutchison, JG, Muir, AJ, Ratziu, V, Afdhal, NH, Goodman, ZD, Bosch, J, and Sanyal, AJ. "Prospective validation of the Enhanced Liver Fibrosis (ELF) test for the prediction of disease progression in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosis." October 2017.

Scholars@Duke

Sofue, K, Burke, LMB, Nilmini, V, Alagiyawanna, M, Muir, AJ, Choudhury, KR, Jaffe, TA, Semelka, RC, and Bashir, MR. "Liver imaging reporting and data system category 4 observations in MRI: Risk factors predicting upgrade to category 5." Journal of magnetic resonance imaging : JMRI 46, no. 3 (September 2017): 783-792.

PMID
28083902
Full Text

Pages